CERT vs LRCX · rev $187.4M vs P/E 71, rev $23.23B
Certara Inc (CERT) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported CERT revenue for 2026-06-30 was $187.4M. Net income was -$64.0M. Revenue was up 75.2% from 2026-03-31 to 2026-06-30. CERT currently screens at market cap $1.86B.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
CERT currently screens at market cap $1.86B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the CERT and LRCX stock pages for the full models.
Not investment advice.